| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0019 | 1 |